Aspecific bronchial hyperreactivity in pulmonary sarcoidosis

Area of Science:

• Pulmonology
• Respiratory Medicine
• Clinical Immunology

Background:

• Aspecific bronchial hyperreactivity (A.B.H.) is a hallmark of asthma but can occur in other respiratory conditions.
• Sarcoidosis is a multisystem inflammatory disease that can affect the lungs.

Purpose of the Study:

• To investigate the prevalence of A.B.H. in patients with pulmonary sarcoidosis.
• To compare A.B.H. in sarcoidosis patients with asthmatic patients and healthy controls.

Main Methods:

• A dosimetric methacholine challenge test was administered to assess A.B.H.
• Study included 30 pulmonary sarcoidosis patients, 27 asthma patients, and 25 healthy controls, matched for age and sex.
• Smoking habits were assessed and found similar between controls and sarcoidosis patients.

Main Results:

• A.B.H. was detected in 20.6% of sarcoidosis patients (p < 0.05).
• While mean PD20FEV1 values did not differ significantly between groups, the difference between asthma and sarcoidosis patients was highly significant (p = 0.003).
• No significant difference in basal FEV1 was observed between asthmatics and sarcoidosis patients.

Conclusions:

• A.B.H. is present in a significant proportion of pulmonary sarcoidosis patients.
• The findings suggest A.B.H. may contribute to the frequent association between sarcoidosis and asthma.
• Further research is warranted to elucidate the relationship between sarcoidosis and bronchial hyperreactivity.